Whether the magnitude and distribution of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy are established at birth, or whether they evolve during the first years of life, is unknown. Accordingly, we conducted serial echocardiographic studies in 39 children with a family history or morphologic evidence of hypertrophic cardiomyopathy. The patients were initially evaluated at 4 to 15 years of age (mean, 11) and most recently at 9 to 20 years (mean, 16). During a follow-up period of 2.5 to 6.8 years (mean, 4), the magnitude and extent of preexisting left ventricular hypertrophy markedly increased in 17 patients and the morphologic appearance of the heart evolved from normal to hypertrophic in 5 others. In these 22 patients the left ventricular wall thickness increased strikingly (by 6 to 23 mm, a change of 101 +/- 62 percent); these increases significantly exceeded those expected as a consequence of normal growth (13 +/- 10 percent; P less than 0.001) and were not associated with symptomatic deterioration or related to subaortic obstruction. We conclude that left ventricular hypertrophy may develop or progress spontaneously in patients with hypertrophic cardiomyopathy during childhood, when body growth is considerable. Since echocardiograms may be normal during childhood--before the morphologic features of hypertrophic cardiomyopathy develop--a single echocardiographic examination of young relatives of patients with hypertrophic cardiomyopathy may not exclude this disease.
This article has been cited by other articles:
Kaski, J. P., Syrris, P., Esteban, M. T. T., Jenkins, S., Pantazis, A., Deanfield, J. E., McKenna, W. J., Elliott, P. M.
(2009). Prevalence of Sarcomere Protein Gene Mutations in Preadolescent Children With Hypertrophic Cardiomyopathy. Circ Cardiovasc Genet
2: 436-441
[Abstract][Full Text]
Maron, B. J., Ho, C. Y.
(2009). Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members.. J Am Coll Cardiol Img
2: 65-68
[Full Text]
Biagini, E., Coccolo, F., Ferlito, M., Perugini, E., Rocchi, G., Bacchi-Reggiani, L., Lofiego, C., Boriani, G., Prandstraller, D., Picchio, F. M., Branzi, A., Rapezzi, C.
(2005). Dilated-Hypokinetic Evolution of Hypertrophic Cardiomyopathy: Prevalence, Incidence, Risk Factors, and Prognostic Implications in Pediatric and Adult Patients. J Am Coll Cardiol
46: 1543-1550
[Abstract][Full Text]
Minakata, K., Dearani, J. A., O'Leary, P. W., Danielson, G. K.
(2005). Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy in Pediatric Patients: Early and Late Results. Ann. Thorac. Surg.
80: 1424-1430
[Abstract][Full Text]
Minakata, K., Dearani, J. A., Schaff, H. V., O'Leary, P. W., Ommen, S. R., Danielson, G. K.
(2005). Mechanisms for Recurrent Left Ventricular Outflow Tract Obstruction After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. Ann. Thorac. Surg.
80: 851-856
[Abstract][Full Text]
Rickers, C., Wilke, N. M., Jerosch-Herold, M., Casey, S. A., Panse, P., Panse, N., Weil, J., Zenovich, A. G., Maron, B. J.
(2005). Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy. Circulation
112: 855-861
[Abstract][Full Text]
Maron, B. J., Seidman, J.G., Seidman, C. E.
(2004). Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol
44: 2125-2132
[Abstract][Full Text]
Maron, B. J., Chaitman, B. R., Ackerman, M. J., Bayes de Luna, A., Corrado, D., Crosson, J. E., Deal, B. J., Driscoll, D. J., Estes, N.A. M. III, Araujo, C. G. S., Liang, D. H., Mitten, M. J., Myerburg, R. J., Pelliccia, A., Thompson, P. D., Towbin, J. A., Van Camp, S. P., for the Working Groups of the American Heart Assoc,
(2004). Recommendations for Physical Activity and Recreational Sports Participation for Young Patients With Genetic Cardiovascular Diseases. Circulation
109: 2807-2816
[Abstract][Full Text]
McMahon, C. J., Nagueh, S. F., Pignatelli, R. H., Denfield, S. W., Dreyer, W. J., Price, J. F., Clunie, S., Bezold, L. I., Hays, A. L., Towbin, J. A., Eidem, B. W.
(2004). Characterization of Left Ventricular Diastolic Function by Tissue Doppler Imaging and Clinical Status in Children With Hypertrophic Cardiomyopathy. Circulation
109: 1756-1762
[Abstract][Full Text]
Maron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H. III, Spirito, P., Ten Cate, F. J., Wigle, E. D., Vogel, R. A., Abrams, J., Bates, E. R., Brodie, B. R., Danias, P. G., Gregoratos, G., Hlatky, M. A., Hochman, J. S., Kaul, S., Lichtenberg, R. C., Lindner, J. R., O'rourke, R. A., Pohost, G. M., Schofield, R. S., Tracy, C. M., Winters, W. L. Jr, Klein, W. W., Priori, S. G., Alonso-Garcia, A., Blomstrom-Lundqvist, C., De Backer, G., Deckers, J., Flather, M., Hradec, J., Oto, A., Parkhomenko, A., Silber, S., Torbicki, A.
(2003). American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol
42: 1687-1713
[Full Text]
Writing Committee Members, , Maron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H. III, Spirito, P., Ten Cate, F. J., Wigle, E. D., ACCF Task Force on Clinical Expert Consensus Docum, , Vogel, R. A., Abrams, J., Bates, E. R., Brodie, B. R., Danias, P. G., Gregoratos, G., Hlatky, M. A., Hochman, J. S., Kaul, S., Lichtenberg, R. C., Lindner, J. R., O'Rourke, R. A., Pohost, G. M., Schofield, R. S., Tracy, C. M., Winters, W. L. Jr, ESC Committee for Practice Guidelines Members, , Klein, W. W., Priori, S. G., Alonso-Garcia, A., Blomstrom-Lundqvist, C., De Backer, G., Deckers, J., Flather, M., Hradec, J., Oto, A., Parkhomenko, A., Silber, S., Torbicki, A.
(2003). American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J
24: 1965-1991
[Full Text]
Sharma, S., Maron, B. J., Whyte, G., Firoozi, S., Elliott, P. M., McKenna, W. J.
(2002). Physiologic limits of left ventricular hypertrophy in elite junior athletes: Relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy. J Am Coll Cardiol
40: 1431-1436
[Abstract][Full Text]
Ho, C. Y., Sweitzer, N. K., McDonough, B., Maron, B. J., Casey, S. A., Seidman, J.G., Seidman, C. E., Solomon, S. D.
(2002). Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy. Circulation
105: 2992-2997
[Abstract][Full Text]
Maron, B. J.
(2002). Hypertrophic Cardiomyopathy: A Systematic Review. JAMA
287: 1308-1320
[Abstract][Full Text]
Roberts, R., Sigwart, U.
(2001). New Concepts in Hypertrophic Cardiomyopathies, Part II. Circulation
104: 2249-2252
[Full Text]
McKenna, W.J., Sharma, S., Elliott, P.M.
(2001). Management strategies in hypertrophic cardiomyopathy: influence of age and morphology. Eur Heart J Suppl
3: L10-L14
[Abstract]
Maron, B. J., Niimura, H., Casey, S. A., Soper, M. K., Wright, G. B., Seidman, J. G., Seidman, C. E.
(2001). Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol
38: 315-321
[Abstract][Full Text]
Spirito, P., Bellone, P., Harris, K. M., Bernabo, P., Bruzzi, P., Maron, B. J.
(2000). Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy. NEJM
342: 1778-1785
[Abstract][Full Text]
Shirani, J., Pick, R., Roberts, W. C., Maron, B. J.
(2000). Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol
35: 36-44
[Abstract][Full Text]
Ostman-Smith, I., Wettrell, G.o., Riesenfeld, T.
(1999). A cohort study of childhood hypertrophic cardiomyopathy: Improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol
34: 1813-1822
[Abstract][Full Text]
Kittleson, M. D., Meurs, K. M., Munro, M. J., Kittleson, J. A., Liu, S.-K., Pion, P. D., Towbin, J. A.
(1999). Familial Hypertrophic Cardiomyopathy in Maine Coon Cats : An Animal Model of Human Disease. Circulation
99: 3172-3180
[Abstract][Full Text]
Spirito, P., Rapezzi, C., Bellone, P., Betocchi, S., Autore, C., Conte, M. R., Bezante, G. P., Bruzzi, P.
(1999). Infective Endocarditis in Hypertrophic Cardiomyopathy : Prevalence, Incidence, and Indications for Antibiotic Prophylaxis. Circulation
99: 2132-2137
[Abstract][Full Text]
Yetman, A. T., Hamilton, R. M., Benson, L. N., McCrindle, B. W.
(1998). Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. J Am Coll Cardiol
32: 1943-1950
[Abstract][Full Text]
Lakkis, N. M., Nagueh, S. F., Kleiman, N. S., Killip, D., He, Z.-X., Verani, M. S., Roberts, R., Spencer, W. H. III
(1998). Echocardiography-Guided Ethanol Septal Reduction for Hypertrophic Obstructive Cardiomyopathy. Circulation
98: 1750-1755
[Abstract][Full Text]
Maron, B. J., Moller, J. H., Seidman, C. E., Vincent, G. M., Dietz, H. C., Moss, A. J., Towbin, J. A., Sondheimer, H. M., Pyeritz, R. E., McGee, G., Epstein, A. E.
(1998). Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan Syndrome : A Statement for Healthcare Professionals From the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association. Circulation
98: 1460-1471
[Full Text]
Charron, P., Dubourg, O., Desnos, M., Isnard, R., Hagege, A., Millaire, A., Carrier, L., Bonne, G., Tesson, F., Richard, P., Bouhour, J.-B., Schwartz, K., Komajda, M.
(1997). Diagnostic Value of Electrocardiography and Echocardiography for Familial Hypertrophic Cardiomyopathy in a Genotyped Adult Population. Circulation
96: 214-219
[Abstract][Full Text]
Cheitlin, M. D., Alpert, J. S., Armstrong, W. F., Aurigemma, G. P., Beller, G. A., Bierman, F. Z., Davidson, T. W., Davis, J. L., Douglas, P. S., Gillam, L. D., Lewis, R. P., Pearlman, A. S., Philbrick, J. T., Shah, P. M., Williams, R. G., Ritchie, J. L., Cheitlin, M. D., Eagle, K. A., Gardner, T. J., Garson, A. Jr, Gibbons, R. J., Lewis, R. P., O'Rourke, R. A., Ryan, T. J.
(1997). ACC/AHA Guidelines for the Clinical Application of Echocardiography : A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) Developed in Collaboration With the American Society of Echocardiography. Circulation
95: 1686-1744
[Full Text]
Spirito, P., Seidman, C. E., McKenna, W. J., Maron, B. J.
(1997). The Management of Hypertrophic Cardiomyopathy. NEJM
336: 775-785
[Full Text]
Theodoro, D. A., Danielson, G. K., Feldt, R. H., Anderson, B. J.
(1996). HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY IN PEDIATRIC PATIENTS: RESULTS OF SURGICAL TREATMENT. J. Thorac. Cardiovasc. Surg.
112: 1589-1599
[Abstract][Full Text]
Maron, B. J., Thompson, P. D., Puffer, J. C., McGrew, C. A., Strong, W. B., Douglas, P. S., Clark, L. T., Mitten, M. J., Crawford, M. H., Atkins, D. L., Driscoll, D. J., Epstein, A. E.
(1996). Cardiovascular Preparticipation Screening of Competitive Athletes: A Statement for Health Professionals From the Sudden Death Committee (Clinical Cardiology) and Congenital Cardiac Defects Committee (Cardiovascular Disease in the Young), American Heart Association. Circulation
94: 850-856
[Full Text]
Maron, B. J., Shirani, J., Poliac, L. C., Mathenge, R., Roberts, W. C., Mueller, F. O.
(1996). Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles. JAMA
276: 199-204
[Abstract]
Wigle, E. D., Rakowski, H., Kimball, B. P., Williams, W. G.
(1995). Hypertrophic Cardiomyopathy : Clinical Spectrum and Treatment. Circulation
92: 1680-1692
[Full Text]
Lechin, M., Quinones, M. A., Omran, A., Hill, R., Yu, Q.-T., Rakowski, H., Wigle, D., Liew, C.C., Sole, M., Roberts, R., Marian, A. J.
(1995). Angiotensin-I Converting Enzyme Genotypes and Left Ventricular Hypertrophy in Patients With Hypertrophic Cardiomyopathy. Circulation
92: 1808-1812
[Abstract][Full Text]
Marian, A.J., Roberts, R.
(1995). Recent Advances in the Molecular Genetics of Hypertrophic Cardiomyopathy. Circulation
92: 1336-1347
[Full Text]
Maron, B. J., Gardin, J. M., Flack, J. M., Gidding, S. S., Kurosaki, T. T., Bild, D. E.
(1995). Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults : Echocardiographic Analysis of 4111 Subjects in the CARDIA Study. Circulation
92: 785-789
[Abstract][Full Text]
Ryan, M. P, French, J., Al-Mahdawi, S., Nihoyannopoulos, P., Cleland, J. G F, Oakley, C. M
(1995). An Ethical Debate: Genetic testing for familial hypertrophic cardiomyopathy in newborn infants: Clinicians' perspective. BMJ
310: 856-857
[Full Text]
Maron, B. J., Pelliccia, A., Spirito, P.
(1995). Cardiac Disease in Young Trained Athletes : Insights Into Methods for Distinguishing Athlete's Heart From Structural Heart Disease, With Particular Emphasis on Hypertrophic Cardiomyopathy. Circulation
91: 1596-1601
[Full Text]
Baughman, K. L.
(1992). Hypertrophic Cardiomyopathy. JAMA
267: 846-849
[Abstract]
MARON, B. J., MULVIHILL, J. J.
(1986). The Genetics of Hypertrophic Cardiomyopathy. ANN INTERN MED
105: 610-613
[Abstract]
Previous
